Published in Medical Letter on the CDC and FDA, January 29th, 2006
Endo also said that, under the Prescription Drug User Fee Act (PDUFA) guidelines, the FDA has 60 days to decide if Endo's submission meets the FDA's criteria for a complete response and, if so, Endo expects that the FDA will issue an action letter for the NDA no later...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA